What's new in COVID-19?

Título

What's new in COVID-19?

Autor

Umar M M A Shareef, Vinod Kumar, Vasantha Kamath

Descripción

COVID-19 has affected over 57,410,025 people and killed more than 1,368,848 of those affected in 220 countries as on November 20, 2020. Community-acquired coronaviruses are ubiquitous with a male preponderance. Unlike Western nations, majority of the cases in India are in the age group of 31–50 years, and the mortality rate is around 1.46%. The possible modes of transmission for severe acute respiratory syndrome coronavirus 2 include droplet, airborne, fomite, fecal-oral, bloodborne, mother-to-child, and animal-to-human transmission as per the World Health Organization. Apart from the known symptoms of influenza-like illness, COVID also presents with cutaneous, hematological, gastrointestinal, and neurological manifestations. In the absence of dedicated cures, until there is a hope of appropriate and effective vaccine development, the novel coronavirus will be a challenge to the existence of humanity.

Fecha

2021

Materia

vaccine, covid-19, airborne

Identificador

10.4103/ajim.ajim_63_20

Fuente

APIK Journal of Internal Medicine

Editor

Wolters Kluwer Medknow Publications

Cobertura

Internal medicine

Archivos

https://socictopen.socict.org/files/to_import/pdfs/2a6570d00d88ec74c1b9736bfa8abc9c.pdf

Colección

Citación

Umar M M A Shareef, Vinod Kumar, Vasantha Kamath, “What's new in COVID-19?,” SOCICT Open, consulta 10 de junio de 2026, https://www.socictopen.socict.org/items/show/6687.

Formatos de Salida

Position: 9078 (30 views)